Allan M. Lund

7.6k total citations
171 papers, 3.3k citations indexed

About

Allan M. Lund is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Allan M. Lund has authored 171 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Clinical Biochemistry, 61 papers in Physiology and 60 papers in Molecular Biology. Recurrent topics in Allan M. Lund's work include Metabolism and Genetic Disorders (63 papers), Lysosomal Storage Disorders Research (39 papers) and Connective tissue disorders research (31 papers). Allan M. Lund is often cited by papers focused on Metabolism and Genetic Disorders (63 papers), Lysosomal Storage Disorders Research (39 papers) and Connective tissue disorders research (31 papers). Allan M. Lund collaborates with scholars based in Denmark, United Kingdom and Germany. Allan M. Lund's co-authors include Flemming Skovby, Gunilla Malm, Nathalie Guffon, Morten Dunø, Michael Beck, Linda De Meırleır, Jan Rasmussen, Ans T. van der Ploeg, J Zeman and Maurizio Scarpa and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Allan M. Lund

162 papers receiving 3.2k citations

Peers

Allan M. Lund
Dwight D. Koeberl United States
Emil Kakkis United States
Paige Kaplan United States
T Orii Japan
Luisa Bonafé Switzerland
Marianne Rohrbach Switzerland
Allan M. Lund
Citations per year, relative to Allan M. Lund Allan M. Lund (= 1×) peers Dau‐Ming Niu

Countries citing papers authored by Allan M. Lund

Since Specialization
Citations

This map shows the geographic impact of Allan M. Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan M. Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan M. Lund more than expected).

Fields of papers citing papers by Allan M. Lund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan M. Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan M. Lund. The network helps show where Allan M. Lund may publish in the future.

Co-authorship network of co-authors of Allan M. Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Allan M. Lund. A scholar is included among the top collaborators of Allan M. Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan M. Lund. Allan M. Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nielsen, Alex Christian Yde, et al.. (2023). High yield on aetiology using a systematic diagnostic approach to paediatric acute liver failure, analysis of a nationwide cohort. Acta Paediatrica. 112(5). 1082–1090. 1 indexed citations
3.
Lund, Allan M., et al.. (2021). Excellent response to asfotase alfa treatment in an adolescent patient with hypophosphatasia. JIMD Reports. 59(1). 10–15. 3 indexed citations
4.
Grünert, Sarah C., Anke Schumann, Allan M. Lund, et al.. (2021). Succinyl-CoA:3-oxoacid coenzyme A transferase (SCOT) deficiency: A rare and potentially fatal metabolic disease. Biochimie. 183. 55–62. 9 indexed citations
5.
Wibrand, Flemming, et al.. (2019). Genotype and phenotype classification of 29 patients affected by Krabbe disease. JIMD Reports. 46(1). 35–45. 10 indexed citations
6.
Christesen, Henrik Thybo, et al.. (2019). Extreme Hypercalcaemia: Watch for Glycogen Storage Disease Type 1a with Hyperinsulinism. University of Southern Denmark Research Portal (University of Southern Denmark). 92. 1 indexed citations
7.
Petersen, Jørgen Holm, Åse Krogh Rasmussen, Allan M. Lund, et al.. (2018). Age-related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study. Nephrology Dialysis Transplantation. 34(9). 1525–1533. 26 indexed citations
8.
Hansen, Dennis Lund, et al.. (2017). Splenomegaly – Diagnostic validity, work-up, and underlying causes. PLoS ONE. 12(11). e0186674–e0186674. 35 indexed citations
9.
Posset, Roland, Ángeles García‐Cazorla, Vassili Valayannopoulos, et al.. (2016). Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders. Journal of Inherited Metabolic Disease. 39(5). 661–672. 49 indexed citations
10.
Lund, Allan M., et al.. (2015). [Splenomegaly and failure to thrive as a result of Gaucher disease].. PubMed. 177(37). V04150358–V04150358. 1 indexed citations
11.
Bayat, Allan, Lisbeth Birk Møller, & Allan M. Lund. (2015). [Diagnostics and treatment of phenylketonuria].. PubMed. 177(8). 2 indexed citations
12.
Valencia, Eulalia, José A. Caparrós‐Martín, Ma Salomé Sirerol-Piquer, et al.. (2014). Report of a newly indentified patient with mutations in BMP1 and underlying pathogenetic aspects. American Journal of Medical Genetics Part A. 164(5). 1143–1150. 24 indexed citations
13.
Rasmussen, Jan, Olav Wendelboe Nielsen, Nils Janzen, et al.. (2013). Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. Journal of Inherited Metabolic Disease. 37(2). 215–222. 64 indexed citations
14.
Rauch, Frank, Pierre Moffatt, Moira Cheung, et al.. (2012). Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.−14C>T mutation in all patients. Journal of Medical Genetics. 50(1). 21–24. 86 indexed citations
15.
Lund, Allan M., et al.. (2012). [Carnitine transporter deficiency is a hereditary disease with a high incidence in the Faroe Islands].. PubMed. 174(18). 1217–9. 8 indexed citations
16.
MacDonald, Anita, M. van Rijn, François Feillet, et al.. (2012). Adherence Issues in Inherited Metabolic Disorders Treated by Low Natural Protein Diets. Annals of Nutrition and Metabolism. 61(4). 289–295. 74 indexed citations
17.
Lund, Allan M., et al.. (2011). [Molecular biological aspects of Marfan syndromes].. PubMed. 173(5). 333–7.
18.
Kibæk, Maria, et al.. (2009). Chromosomal deletion unmasking a recessive disease: 22q13 deletion syndrome and metachromatic leukodystrophy. Clinical Genetics. 75(2). 175–179. 28 indexed citations
19.
Lund, Trine Meldgaard, Erik Christensen, Anders S. Kristensen, Arne Schousboe, & Allan M. Lund. (2004). On the neurotoxicity of glutaric, 3‐hydroxyglutaric, and trans‐glutaconic acids in glutaric acidemia type 1. Journal of Neuroscience Research. 77(1). 143–147. 27 indexed citations
20.
Agerholm, Jørgen Steen, Allan M. Lund, B. Bloch, et al.. (1994). Osteogenesis Imperfecta in Holstein‐Friesian Calves. Journal of Veterinary Medicine Series A. 41(1-10). 128–138. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026